Endometrial cancer starts in the tissue that lines your uterus. If the cancer is platinum-resistant, platinum-based chemotherapy drugs will not work well to kill it or stop it from returning after ...

endometrial_order$Cell_Line[endometrial_order$Cell_Line == "IshikawaHeraklio02ER"] <- "Ishikawa" endometrial_order$VAF <- factor(endometrial_order$VAF, levels= c("WT ...

Managing endometrial cancer can be very stressful. Taking steps to support your emotional and mental health is important for improving your quality of life with this condition. An endometrial ...

China Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with rising incidence in recent years. Experimental animal models are crucial for studying the ...

Background: Radiomics can capture microscale information in medical images beyond what is visible to the naked human eye. Using a clinically relevant mouse model for endometrial cancer, the objective ...

Alarming racial disparities in cancer mortality also persist. American Indian and Alaska Native (AIAN) people are 2 to 3 times more likely to die from cancers of the cervix, kidney, liver, and stomach ...

IMA-402 is under clinical development by Immatics and currently in Phase II for Uterine Cancer. According to GlobalData, Phase II drugs for Uterine Cancer have a 30% phase transition success rate ...

An NDA has been accepted by the FDA for the combination of avutometinib and defactinib in KRAS-mutated recurrent low-grade serous ovarian cancer. As we near the end of 2024, CURE is looking back at ...

The goal is to treat various solid tumors, including gynecological cancers such as breast cancer, ovarian cancer, and endometrial cancer ... Following the Phase 1a dose escalation trial, a ...

Jan. 15, 2025 — In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive ...